#Headlines

‘Substandard medicines pose challenge to healthcare system’

Jan 13, 2025, 10:00 AM | Article By: Ismaila Sonko

As he emphasised the significance of the availability of safe and effective medicines in ensuring the wellbeing of individuals and the general public of nations, Dr Jerreh Sanyang, the board chairperson Medicine Control Agency (MCA), has bemoaned that substandard and falsified medicines pose significant threat to healthcare systems globally.

Dr Sanyang made this discourse at the launching of the National Substandard and Falsified Medicines (NSFM) Plan at a local hotel.

He said substandard and falsified medicines, often referred to as SF medicines are pharmaceutical products that do not meet the required quality standards for efficacy, safety, and identity, thereby posing serious risks to patients and public health.

These products, Jerreh noted may contain incorrect ingredients, insufficient active ingredients, contaminants, or improper packaging and labeling. “The widespread circulation of SF medicines continues to pose substantial threat to public health, leading to ineffective treatment and increased risk of adverse health outcomes.”

He added: “The prevention, detection and response to substandard and falsified medicines and related products are the mandate of Medicine Control Agency in collaboration with the stakeholders.

Dr Sanyang delved into the National Substandard and Falsified Medicines (NSFM) Plan, which he said would ensure access to quality, safe and efficacious medicines for the people of The Gambia. “It will provide the road map for different activities that will ensure prevention, timely detection and rapid response for any substandard and falsified medicine.”

Read Other Articles In Headlines